Savara SVRA
NASDAQ SVRA
$4.85 -0.14 (-2.81%)
As of: Nov 12, 2026 · 11:07 AM EST

Savara (SVRA) Return on Invested Capital [ROIC] (2017 - 2021)

Updated

Savara (SVRA) recorded Return on Invested Capital [ROIC] of -50.85% in Q4 2018, down 26.94 percentage points from -23.90% a year earlier and down 0.39 percentage points from the prior quarter.

Analysis

Savara (SVRA) Return on Invested Capital [ROIC] (2017 - 2021) Analysis & Trends

For FY2018, Savara reported Return on Invested Capital [ROIC] of -47.10%, up 5.23 percentage points from FY2017.

  • Across earlier years, Return on Invested Capital [ROIC] came in at -52.33% in FY2017.
  • Per Business Quant, the preceding three quarters came in at -50.46% (Q3 2018), -50.43% (Q2 2018) and -40.92% (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Savara 1.09 Bn 407.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 -23.61%
Sep 30, 2020 -64.49%
Sep 30, 2019 -45.11%
Dec 31, 2018 -50.85%
Sep 30, 2018 -50.46%
Jun 30, 2018 -50.43%
Mar 31, 2018 -40.92%
Dec 31, 2017 -23.90%
API Access

Savara Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=SVRA&period=max&api_key=YOUR_API_KEY